Option Care Health, Inc. (OPCH)
OPCH Stock Price Chart
Explore Option Care Health, Inc. interactive price chart. Choose custom timeframes to analyze OPCH price movements and trends.
OPCH Company Profile
Discover essential business fundamentals and corporate details for Option Care Health, Inc. (OPCH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
15 Aug 1996
Employees
8.00K
Website
https://www.optioncarehealth.comCEO
John C. Rademacher
Description
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
OPCH Financial Timeline
Browse a chronological timeline of Option Care Health, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Oct 2025
EPS estimate is $0.43, while revenue estimate is $1.41B.
Earnings released on 30 Jul 2025
EPS came in at $0.41 surpassing the estimated $0.40 by +2.50%, while revenue for the quarter reached $1.42B , beating expectations by +0.96%.
Earnings released on 29 Apr 2025
EPS came in at $0.40 surpassing the estimated $0.36 by +11.11%, while revenue for the quarter reached $1.33B , missing expectations by -0.24%.
Earnings released on 26 Feb 2025
EPS came in at $0.35 surpassing the estimated $0.33 by +6.06%, while revenue for the quarter reached $1.35B , beating expectations by +9.49%.
Earnings released on 30 Oct 2024
EPS came in at $0.31 matching the estimated $0.31, while revenue for the quarter reached $1.28B , beating expectations by +0.71%.
Earnings released on 31 Jul 2024
EPS came in at $0.30 surpassing the estimated $0.27 by +11.11%, while revenue for the quarter reached $1.23B , beating expectations by +4.91%.
Earnings released on 23 Apr 2024
EPS came in at $0.26 surpassing the estimated $0.23 by +13.04%, while revenue for the quarter reached $1.15B , beating expectations by +4.02%.
Earnings released on 22 Feb 2024
EPS came in at $0.32 surpassing the estimated $0.29 by +10.34%, while revenue for the quarter reached $1.12B , beating expectations by +3.09%.
Earnings released on 25 Oct 2023
EPS came in at $0.31 surpassing the estimated $0.28 by +10.71%, while revenue for the quarter reached $1.09B , beating expectations by +0.31%.
Earnings released on 27 Jul 2023
EPS came in at $0.63 surpassing the estimated $0.22 by +186.36%, while revenue for the quarter reached $1.07B , beating expectations by +0.51%.
Earnings released on 3 May 2023
EPS came in at $0.21 surpassing the estimated $0.18 by +16.67%, while revenue for the quarter reached $1.02B , beating expectations by +1.70%.
Earnings released on 23 Feb 2023
EPS came in at $0.22 matching the estimated $0.22, while revenue for the quarter reached $1.03B , beating expectations by +0.42%.
Earnings released on 27 Oct 2022
EPS came in at $0.21 matching the estimated $0.21, while revenue for the quarter reached $1.02B , beating expectations by +2.47%.
Earnings released on 27 Jul 2022
EPS came in at $0.19 falling short of the estimated $0.22 by -13.64%, while revenue for the quarter reached $980.82M , beating expectations by +4.24%.
Earnings released on 28 Apr 2022
EPS came in at $0.17 surpassing the estimated $0.13 by +30.77%, while revenue for the quarter reached $915.78M , beating expectations by +8.99%.
Earnings released on 23 Feb 2022
EPS came in at $0.24 matching the estimated $0.24, while revenue for the quarter reached $927.19M , beating expectations by +1.04%.
Earnings released on 4 Nov 2021
EPS came in at $0.20 surpassing the estimated $0.19 by +5.26%, while revenue for the quarter reached $891.94M , beating expectations by +0.95%.
Earnings released on 3 Aug 2021
EPS came in at $0.18 surpassing the estimated $0.09 by +100.00%, while revenue for the quarter reached $860.27M , beating expectations by +7.74%.
Earnings released on 6 May 2021
EPS came in at -$0.02 falling short of the estimated -$0.01 by -199.85%, while revenue for the quarter reached $759.24M , missing expectations by -4.26%.
Earnings released on 11 Mar 2021
EPS came in at $0.10 surpassing the estimated $0.07 by +42.86%, while revenue for the quarter reached $804.71M .
Earnings released on 3 Nov 2020
EPS came in at $0.01 surpassing the estimated $0.00 by +122.72%, while revenue for the quarter reached $781.61M , missing expectations by -75.00%.
OPCH Stock Performance
Access detailed OPCH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.